Continued Early Intervention for Recent-onset Schizophrenia
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00184509|
Recruitment Status : Terminated
First Posted : September 16, 2005
Last Update Posted : January 26, 2017
|Condition or disease||Intervention/treatment||Phase|
|Schizophrenia||Behavioral: integrated psychosocial treatment (behavior)||Phase 3|
Early intervention for schizophrenia has spawned considerable enthusiasm among clinicians without solid research evidence to suport its benefits and costs. The present study is a random-controlled study of integrated biomedical and psychosocial treatment on a population of recent-onset cases.
Comparison(s): 50 consecutive referrals with schizophrenic disorders of less than two years duration were allocated randomly to a comprehensive model of integrated treatment or standard care for two years. Main outcome measures was psychopathology, psychosocial functioning and hospital admissions.
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||50 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Continued Early Intervention for Recent-onset Schizophrenia. A Randomized Controlled Study.|
|Study Start Date :||February 1993|
|Study Completion Date :||May 1998|
- Rehospitalizations and psychotic relapse at two years
- Psychopathology, psychosocial changes, functioning, antipsychotic medication
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00184509
|Norwegian University of Science and Technology|
|Trondheim, Norway, N-7000|
|Study Director:||K. Gunnar Gøtestam, MD||Norwegian University of Science and Technology|